Clinical trial Recruiting at 4 sites Interventional Ages 18 and up

Peer navigation support for Hispanic parents of children with cancer

Official title: Multisite Implementation of COMPRENDO (ChildhOod Malignancy Peer REsearch NavigatiOn) to Improve Participation of Hispanic Children in Cancer Clinical Trials

Run by University of California, San Diego · NCT06055296 · Data updated 2026-11-12

This study tests whether having trained peer supporters can help Hispanic parents of children with cancer get involved in clinical trials better than standard care.

More Pediatric Cancer trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment450 (estimated)
SponsorUniversity of California, San Diego
Academic / other
Locations4 sites (Birmingham, Alabama and 3 other locations)
StatusRecruiting
StartedJanuary 11, 2024
Main results expectedDecember 31, 2027
Study endsJune 30, 2028
Registry record updatedJune 3, 2026
Trial IDNCT06055296 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are Hispanic parents or legal guardians of children aged 0-17 with newly diagnosed cancer or cancer-like diseases who are eligible for a therapeutic clinical trial.

Probably not a fit

Patients who have a second malignancy, are diagnosed at an outside institution, or do not understand written and spoken English or Spanish may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

COMPRENDO is a multi-site randomized clinical trial designed to evaluate the effectiveness of a peer-navigation intervention compared to usual care for increasing participation in childhood cancer clinical trials. The intervention involves trained peer navigators who will assist parents through four visits, focusing on informed consent and decision-making processes. The study will also assess implementation factors through mixed methods, including surveys and interviews with various stakeholders, to enhance the integration of peer navigation in clinical practice. Approximately 400 participants will be involved, with a focus on Hispanic families facing newly diagnosed pediatric cancers.

Why it matters

Potential benefit: If successful, this intervention could significantly improve clinical trial enrollment and parental understanding of informed consent in pediatric cancer care.

How similar studies have gone: Other studies have shown success with peer navigation interventions in improving clinical trial accrual and informed consent processes, indicating a promising approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Non-Stakeholder/Stakeholder Parent Eligibility criteria: A parent/legal guardian who has a Hispanic child aged 0 to 17y with a new diagnosis of cancer, has a child who is eligible for a therapeutic cancer clinical trial, will participate in an informed consent discussion for the therapeutic clinical trial, understands written and spoken English or Spanish, and has signed the consent form for the proposed COMPRENDO study. Participants will not be eligible if their child has second malignancy/relapse, was diagnosed at an outside institution, has potential transfer of care, was previously on a clinical trial

Stakeholder Clinician/Navigator/Administrator Clinicians, navigators and administrators who work at each site, are involved in treating pediatric patients and who are involved in the informed consent conference for clinical trials.

Where it's running

  • Children's of Alabama/University of Alabama at Birmingham
    Birmingham, Alabama, United States
    Recruiting
  • Rady Children's Hospital San Diego/University of California San Diego Moores Cancer Center
    San Diego, California, United States
    Recruiting
  • University of California San Francisco Benioff Children's Hospitals
    San Francisco, California, United States
    Recruiting
  • Dana Farber Cancer Institute/Boston Children's Hospital
    Boston, Massachusetts, United States
    Recruiting

Study contacts

  • Principal investigator: M.Paula Aristizabal, MD, MAS — University of California, San Diego
  • Study coordinator: M.Paula Aristizabal, MD, MAS
  • Email: paristizabal@rchsd.org
  • Phone: 858-966-5811

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.